Thursday, March 14, 2013

One gene, many mutations: Key that controls coat color in mice evolved nine times

Mar. 14, 2013 ? For deer mice living in the Nebraska Sandhills, color can be the difference between life and death.

When the dark-coated mice first colonized the region, they stood out starkly against the light-colored, sandy soil, making them easy prey for predators. Over the next 8,000 years, however, the mice evolved a system of camouflage, with lighter coats, changes in the stripe on their tails, and changes in body pigment that allowed them to blend into their habitat.

Now Harvard researchers are using their example to answer one of the fundamental questions about evolution. Is it a process marked by large leaps -- single mutations that result in dramatic changes in an organism -- or is it the result of many smaller changes that accumulate over time?

As described in a March 15 paper in the journal Science, a team of researchers, including former Harvard postdoctoral fellow Catherine Linnen, now an assistant professor at the University of Kentucky, and led by Hopi Hoekstra, Harvard professor of organismic and evolutionary biology and molecular and cellular biology, were able to show that the changes in mouse coat color were the result not of a single mutation but of at least nine mutations within a single gene.

"The findings demonstrate how the cumulative effect of natural selection, acting on many small genetic changes, can produce rapid and dramatic change," said Linnen, the first author of the paper. "This helps us to understand, from a genetic perspective, the uncanny fit between so many organisms and their environments. By acting on many small changes, rather than a handful of large ones, natural selection can produce very finely honed adaptations."

Surprisingly, Hoekstra said, that honing occurred in a single gene.

The role of this gene, called agouti, in camouflage was first discovered by Linnen, Hoekstra, and colleagues in 2009, and it is responsible for changes in pigmentation in the coats of many animals. Every domesticated black cat, for example, has a DNA deletion in the gene.

What surprised Hoekstra and her team, however, wasn't that the gene was involved, but that each of the nine mutations were tied to a unique change in the animal's coats, that all the new mutations led to more camouflaging color, and that the mutations occurred in a relatively short, 8,000-year timeframe.

"Essentially, it seems as though these mutations -- each of which makes the mouse a little lighter and more camouflaged -- have accumulated over time," Hoekstra said.

Focusing on these mutations, researchers then examined the DNA of natural populations of the mice to determine whether the mutations are actually beneficial.

"For each of the mutations associated with color change, we also find a signal that's consistent with positive selection," Hoekstra said. "That implies that each of the specific changes to pigmentation is beneficial. This is consistent with the story we are telling, about how these mutations are fine-tuning this trait."

While the findings offer valuable insight into the way that natural selection operates, Hoekstra said they also highlight the importance of following research questions to their ultimate end.

"The question has always been whether evolution is dominated by these big leaps or smaller steps," she said. "When we first implicated the agouti gene, we could have stopped there and concluded that evolution takes these big steps as only one major gene was involved, but that would have been wrong. When we looked more closely, within this gene, we found that even within this single locus, there are, in fact, many small steps."

Going forward, Hoekstra said, her team hopes to understand the order in which the mutations happened, which would allow it to reconstruct how the mice changed over time.

"For evolutionary biologists, this is exciting because we want to learn about the past, but we only have data from the present to study it," she said. "This ability to go back in time and reconstruct an evolutionary path is very exciting, and I think this data set is uniquely suited for this type of time travel."

Taking the time to understand not only which genes are involved but which specific mutations may be driving natural selection, Hoekstra said, can give researchers a much fuller picture of not only the molecular mechanisms by which mutations alter traits, but also the evolutionary history of an organism.

"By doing this, we've discovered all kinds of new things," she said. "While we often think about changes happening in the entire genome, our results suggest that even within a very basic unit -- the gene -- we can see evidence for evolutionary fine-tuning."

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by Harvard University. The original article was written by Peter Reuell.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. C. R. Linnen, Y.-P. Poh, B. K. Peterson, R. D. H. Barrett, J. G. Larson, J. D. Jensen, H. E. Hoekstra. Adaptive Evolution of Multiple Traits Through Multiple Mutations at a Single Gene. Science, 2013; 339 (6125): 1312 DOI: 10.1126/science.1233213

Note: If no author is given, the source is cited instead.

Disclaimer: Views expressed in this article do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/most_popular/~3/WgoAO1uwBrE/130314180303.htm

billy crystal oscars 2012 angelina jolie oscars chardon high school christopher plummer viola davis school shooting in ohio shooting at chardon high school

Bitcoin add-on makes your virtual purchases private

Hal Hodson, technology reporter

Bitcoin is the perfect currency in many ways. The distributed network that governs the creation and distribution of this digital money means there's no need for central banks, no centralised control, nothing to come between you and your cash.

But it does have a privacy problem. The lack of need for a bank or any central authority is derived through the distributed Bitcoin network, which verifies all transfers across multiple nodes to ensure that no coin is spent twice. This means a record is kept of all transactions between accounts, known as wallets. Although there's nothing that immediately links these accounts with real people, it's relatively easy to link purchases and figure out who's spending what.

Researchers at Johns Hopkins University in Baltimore, Maryland, have come up with a way around this problem. Called Zerocoin, it's a cryptographic add-on to Bitcoin that allows for transactions which cannot be linked together. The key is that it does this without introducing any new centralised elements into the network or using laundering, whereby coins are spent through intermediaries to hide the root purchaser's wallet address.

Zerocoin works by allowing Bitcoin users to leave their coins floating on the network for someone else to redeem, on the condition that they can redeem the same amount of Bitcoin, similarly left floating on the network, at an arbitrary time in the future.

"Anyone can put Bitcoins in, and anyone else can take one out," explains Johns Hopkins researcher Matt Green. "The anonymity comes from the fact that there will be a lot of people doing this. It makes a pool of hidden coins from which anyone can withdraw.".

Green says that he and his fellow researchers are not interested in facilitating criminal activity with Zerocoin. "Zerocoin would give you this incredible privacy guarantee, then we could add on some features which let the police, for instance, to be able to track money laundering. A back door." The paper is due to be presented at the IEEE Symposium on Security & Privacy in Oakland, California, in May.

The lack of any centralised infrastructure affects Bitcoin in other ways too. Since it's backed and regulated cryptographically, bugs in the code that underlies Bitcoin can affect its behaviour. This happened yesterday when an unforeseen bug in the latest version of the Bitcoin software led to a 25 per cent drop in value.

Source: http://feeds.newscientist.com/c/749/f/10897/s/29878c4d/l/0L0Snewscientist0N0Cblogs0Conepercent0C20A130C0A30Cbitcoin0Ezerocoin0Bhtml0Dcmpid0FRSS0QNSNS0Q20A120EGLOBAL0Qonline0Enews/story01.htm

the big c the visitor king of kings ostara masters 2012 andy kaufman tom watson

Facebook's About Page Redesign Is A Graph Search Data Grab

url-6Years ago Facebook made a wildly successful data grab by putting About details at the top of the profile. Now with its Timeline redesign's "Suggested" sections, Facebook could fill out graph search by making it easy to select and show off where you've been, what you Like, and what you've watched, read, and listened to. And Facebook does more with that data than you might expect.

Source: http://feedproxy.google.com/~r/Techcrunch/~3/uYIdVV4hOYs/

anchorman 2 kentucky basketball oaksterdam the fray national anthem dallas tornado ncaa basketball oikos

Wednesday, March 13, 2013

High-dose oral vitamins, minerals do not reduce recurrent cardiac events in heart attack patients

Mar. 11, 2013 ? Heart attack patients given a combination of high-dose oral vitamins and minerals do not exhibit a significant reduction in recurrent cardiac events, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. However, the results of one component of the NIH-funded Trial to Assess Chelation Therapy (TACT) study, shows that when combined with active chelation therapy, high-dose vitamins and minerals may provide some additional benefit.

The TACT study tested the safety and effectiveness of both EDTA chelation therapy and high-dose vitamin/mineral supplements in individuals with prior heart attacks.

Previous results presented in November 2012 suggested that chelation treatment, with or without supplements, provided a modest reduction in cardiac events compared to a placebo treatment. These cardiac events were combined and included recurrent heart attack, stroke, coronary revascularization, hospitalization for angina and death.

The presentation today focused on the effects of the vitamin/mineral supplements, with or without chelation, compared to placebo caplets, as well as the comparative results of all four study groups (active chelation plus active oral vitamins, active chelation plus placebo oral vitamins, placebo chelation plus active oral vitamins, and placebo chelation plus placebo oral vitamins).

"We did not see a significant benefit of vitamins alone for patients who had a heart attack," said Gervasio A. (Tony) Lamas, MD, lead author of the study and chief of the Columbia University Division of Cardiology at Mount Sinai Medical Center in Miami Beach, Fla. "Interestingly, patients who received both high dose vitamins and active chelation compared to placebo of both appeared to have additional benefit, but more research is needed to understand the results."

Since 1956, alternative medicine practitioners have used EDTA chelation to treat cardiovascular disease. Chelation therapy involves multiple intravenous infusions of a synthetic amino acid called EDTA, which binds to certain minerals and metals, including calcium, lead and cadmium. The study investigators proposed studying chelation and high dose vitamins as separate and combined components to determine potential individual and synergistic effects of the two treatments.

TACT enrolled 1,708 patients with prior heart attacks who were randomly assigned to an active or placebo chelation group and an active or placebo vitamin group. This 2 x 2 factorial design allowed the investigators to clarify the independent contributions of each treatment. Patients received 40 intravenous chelation treatments (or placebo), each lasting about three hours, over about a year and a half.

They were also assigned to take three pills twice daily, which contained either high-dose vitamins and minerals or placebo. Average follow-up was over four years. About half of the patients enrolled in the trial stopped taking the vitamins during the study follow-up; researchers say patient preference was the leading reason, given the number of caplets taken daily.

The primary comparison of the study, oral vitamins and minerals versus an oral placebo, did not show a significant reduction in the primary endpoint: 27 percent in the vitamin group and 30 percent of those receiving, placebo.

The analysis of the four study groups showed that the active/active arm had 108 (26 percent) events and the placebo/placebo arm had 139 (32 percent) events -- a statistically significant difference.

The patients in the trial were 82 percent male, 94 percent Caucasian and about half were obese. All had experienced a previous heart attack. Thirty-two percent had diabetes, 68 percent had high blood pressure and 83 percent had previously undergone bypass surgery, stent implantation or balloon angioplasty. Patients were followed for an average of 55 months. The trial was conducted in 134 sites in the United States and Canada from 2002-2011.

Upon entering the study, many patients were already taking evidence-based medications: 84 percent took daily aspirin to reduce risk of stroke and heart attack, 72 percent were on beta-blockers to treat high blood pressure and 73 percent took statins to treat high cholesterol.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by American College of Cardiology, via EurekAlert!, a service of AAAS.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/heart_disease/~3/TjmUPkD9Ma0/130312102618.htm

dr seuss birthday romney michigan derrick williams railgun jk rowling new book between two ferns statins

Adding Electronics products to my shopping website from Focalprice ...

Tax Type Tax Rate Tax ID or Company no.

eg. VAT, GST ? Registration no.

Source: http://www.freelancer.com/projects/Data-Entry-copy-typing/Adding-Electronics-products-shopping.html

Victoria Secret Bath And Body Works Dicks Sporting Good office max office max jcp Sports Authority

A lesson from the Iraq invasion: Delusion is worse than lies

By Jeff Greenfield

Next Tuesday, March 19, marks the 10th anniversary of the US invasion of Iraq; a war propelled by the assertion that Saddam Hussein?s regime possessed weapons of mass destruction that threatened the U.S.

In the memorable words of then-National Security Adviser Condoleezza Rice, ?We don?t want the smoking gun to be a mushroom cloud.?

Later, when Iraq descended into chaos and quagmire and those weapons of mass destruction turned out to be non-existent, opponents of the war had a simple explanation: ?Bush lied, people died.?

For the elders among us, it was reminiscent of the assertion a generation ago that President Lyndon Johnson and his advisors had lied the country into a massive escalation in Vietnam; by using two 1964 incidents in the Gulf of Tonkin, they were able to win a congressional resolution more or less enabling Johnson to use whatever force he deemed necessary in Southeast Asia. (Later evidence showed that one of the alleged ?attacks? on US Naval vessels almost certainly did not happen).

If you?re looking for false information flowing from the highest levels of government about Iraq, there?s certainly no shortage of examples. President Bush, Vice President Cheney, and Defense Secretary Rumsfeld repeatedly asserted that there was ?no doubt? Saddam possessed weapons of mass destruction; Rumsfeld went so far as to suggest where the weapons were.

But I?m not sure that ?lying? is the most dangerous attribute of leadership. When it comes to genuinely awful consequences, my vote is squarely with ?delusion??an honestly held belief based on misapprehension, ignorance, or willful blindness.

The men who led us into war in Vietnam, for instance, genuinely believed in the ?domino? theory?the idea that the fall of one nation into Communist hands would lead to the fall of an entire region. (They made little or no distinction among different kinds of Communists.)

In early 1961 a new president, John F. Kennedy, was told by military leaders and civilian officials that the Kingdom of Laos -- of no conceivable strategic importance to the U.S. -- required the presence of American troops and perhaps even tactical nuclear weapons. Why? Because if Laos fell, Asia would go red from Thailand to Indonesia.

When Lyndon Johnson escalated the war in 1965 with the bombing of North Vietnam and the introduction of 175,000 ground troops, he knew the possibility of disaster. Months earlier (as White House tapes show), he and Georgia Senator Richard Russell had been despairing over the poor prospects for success.

?It's the damn worse mess that I ever saw," Russell said.? ?And I don't see how we're ever going to get out of it without fighting a major war."

?Well,? Johnson replied, ?that's the way I have been feeling for six months.?

But Johnson was convinced the loss of South Vietnam would not only be politically disastrous, but could produce conditions that would lead to a third World War. The president and his advisers could not see a circumstance in which a unified Vietnam, under an authoritarian Communist regime, would not pose a clear and present danger to the U.S.

The men and women who led us into Iraq had their own domino theory?a ?benign? domino theory, to be sure. A free Iraq would encourage a democracy movement in Iran, which could lead to the removal of the mullahs, which would drain resources from Iran-backed groups like Hezbollah, which would push the Palestinians to a peace accord with Israel, which would spur reform in Saudi Arabia, which?

Out of such delusions, it was easy to see how Vice President Cheney and others could promise that we would be ?greeted as liberators? in Iraq, or why so many lawmakers would see Saddam Hussein?s posturing as proof that he had WMDs, rather than as a dictator?s effort to fool his enemies into passivity.

Delusions, then, can pull decision-makers into steps with a force more powerful than deceit; indeed, they can lead those in power to offer false and misleading assertions in pursuit of a ?greater truth??a ?truth? that itself cannot withstand tough scrutiny.

Of course we must shield pedophiles in our church, because our church proclaims ultimate truths, and must not be weakened by such revelations. (Of course we must give high ratings to suspect financial products, because without confidence in these products, the whole enterprise might collapse.)

To be clear, I hold no brief for mendacity. I just fear a devoutly held delusion more.

Source: http://news.yahoo.com/worse-than-lies-185340802.html

Barcelona New Pope New pope 2013 Conclave The Bachelor 2013 reggie bush tiger woods

Tuesday, March 12, 2013

How to complain: Squeaky wheel still gets the grease

By Herb Weisbaum, TODAY contributor

Most people who have a complaint don?t really push for a solution. They make a quick phone call or send an email, but if they get the brush-off, they?re done.

The fact is, if you want to get your problem solved, you need to speak up and stand your ground until the company makes you happy.

?Yes, it?s the squeaky-wheel system of customer service,? said Amy Schmitz, a law professor at the University of Colorado. Her study ?Access to Consumer Remedies in the Squeaky-Wheel System? was published in the Pepperdine Law Review.

Schmitz believes some companies would rather give customers the runaround than deal with their complaint.

?It appears deliberate,? she told me. ?If they know they can save money by only providing remedies to those who are most persistent, businesses may be able to maximize their profits and elude legitimate complaints.?

If you know how to complain and are willing to be a squeaky wheel, you?re more likely to be successful.

?Don?t give up,? she said. ?Otherwise you will be ignored.?

To find out how to complain, I spoke with Ruth Susswein at Consumer Action. They?ve published a step-by-step booklet on how to get results when you complain. Here are the highlights of our conversation:

Q: What are the most important things to remember when we?re going to complain?

A: ?Be calm, be firm and be concise. Decide what you?re looking for. What?s the outcome you want? Do you want your money back?? Do you want a new product? Or do you just want to vent and get an apology??

I?ve seen complaint letters that go on and on about the problem, but never explain what the customer is looking for. Figure out what you want. Briefly state the problem and what you expect the solution to be.

Q: You say it?s important to complain right away. Why does that matter?

A: There are certain kinds of complaints that have deadlines attached to them. For example, you have 60 days after you receive a credit card statement with a charge on it that you intend to dispute, to write a complaint letter to the credit card company. There?s often a time limit for a health insurance appeal. If there?s a deadline related to your complaint, don?t miss it.

Q: Is there a right forum to complain? How do you know whether to use the customer service line, write a letter or send an email? How do you decide where to begin?

A: Sometimes it doesn?t matter. It all depends on the type of complaint. Ultimately, you want your complaint in writing. You can start calling the company, but you need to follow-up in writing. You want some proof that you made that complaint and the only way to do that is by putting it in writing.

Q: What about records that document your complaint?

A: The more records you have, the better. If you have proof, provide copies of that proof to help make your case. Never send originals. So for example, if you have a receipt that shows when you bought the item and how much you paid for it, send a copy with your complaint letter.

Q: What if you explain the problem, document your case and you still get turned down?

A: Then you need to escalate; take your problem to the next level. It may be the CEO of a company; it may be that you have to turn to a regulator, a government agency that oversees this kind of industry. There are lots of places to turn. No matter what sort of complaint you have, there?s probably a government agency to turn to if your complaint is unresolved.

Q: Odds are the CEO won?t read your letter, but that?s not the point, right?

A: Right. Someone in the CEO?s office is going to take it seriously and will direct your complaint to someone who hopefully can resolve it swiftly.

Q: So your advice is: if I have what I believe to be a legitimate complaint and I?m being ignored, don?t give up.

A: Absolutely! ?Go after it again and again. In the case of a health insurance claim, you may have to re-appeal a decision. You need to be persistent, but also patient, calm and ?in control. The way to get the best results is to stay calm.?

Herb Weisbaum is The ConsumerMan. Follow him on Facebook and Twitter or visit The ConsumerMan website.?

Do you have a success story about complaining and getting good customer service? Share your story in the comment field.

?

Source: http://lifeinc.today.com/_news/2013/03/11/17238936-how-to-complain-squeaky-wheel-still-gets-the-grease?lite

grammy red carpet grammy award winners the band perry grammy awards whitney houston autopsy dobie gray bruce springsteen